
Evotec and Janssen team up in immunooncology
Hamburg-based Evotec SE has entered into a R&D and licencing agreement with Janssen Biotech, a J&J subsidiary to develop immune-based...

Ultra-processed foods increase risk for cancer
According to a long-term data from the UK biobank, high consumption of ultra-processed foods are linked to bad health outcomes such as diabetes,-...

Amgen wins race of top `22 deals with $26bn for Horizon thx
Horizon confirmed Amgen's interest in a press release. The American group is to offer around $116.5 for each share. The offer price is about 20...

Chong Kun Dang Pharm licences Synaffix ADC platform
Though the companies did not give any financial details, former licencing deals of Synaffix to global pharma companies such as Amgen or ranged...

New EU stakeholder platform to speed up clinical trials
Following strong criticism ahead of the mandatory launch of the CTIS electronic clinical trial reporting portal by the European Medicines Agency...

Novo Nordisk funds API manufacturing with €726m
Novo Nordisk’s latest expansion of R&D as well as production capacity is motivated by the need to generate more of its GLP-1 agonist semaglutide,...

Healthcare investments in Catalonia at record high
According to the 2021 BioRegion of Catalonia Report, the medical technology sector attracted most of the money, fueled by two large operations....